Cas:94507-28-5 3,4-dihydro-2H-[1,3]oxazino[2,3-b]quinazolin-6-one manufacturer & supplier

We serve Chemical Name:3,4-dihydro-2H-[1,3]oxazino[2,3-b]quinazolin-6-one CAS:94507-28-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3,4-dihydro-2H-[1,3]oxazino[2,3-b]quinazolin-6-one

Chemical Name:3,4-dihydro-2H-[1,3]oxazino[2,3-b]quinazolin-6-one
CAS.NO:94507-28-5
Synonyms:2,3-dihydro-2H,6H-<1,3>oxazino<2,3-b>quinazolin-6-one;3,4-Dihydro-2H,6H-<1,3>oxazino<2,3-b>quinazolin-6-one;2H,3H,4H,6H-[1,3]oxazino[2,3-b]quinazolin-6-one;2,3,4,5-tetrahydro-[1,3]oxazino[2,3-b]quinazolin-6-one
Molecular Formula:C11H10N2O2
Molecular Weight:202.20900
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:343.4ºC at 760mmHg
Density:1.4g/cm3
Index of Refraction:1.69
PSA:44.12000
Exact Mass:202.07400
LogP:1.17900

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2,3-dihydro-2H,6H-&lt chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,3,4,5-tetrahydro-[1,3]oxazino[2,3-b]quinazolin-6-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,oxazino&lt Use and application,2,3-dihydro-2H,6H-&lt technical grade,usp/ep/jp grade.


Related News: The FDA regulates cosmetics, but the cosmetics industry itself is responsible for assessing the health and safety of ingredient, and there’s not much FDA oversight of that process,” Bruton said.
The Personal Care Products Council, which represents the cosmetics industry, did not have comment on the findings.
A new study finds that many mass shooters in America suffered from a mental illness that wasn’t being treated when they committed their crime.
“Without losing sight of the larger perspective that most who are violent are not mentally ill, and most of the mentally ill are not violent, our message is that mental health providers, lawyers and the public should be made aware that some unmedicated patients do pose an increased risk of violence,” wrote researchers led by Dr. Ira Glick, from Stanford University’s School of Medicine.
Glick’s team studied 35 mass shooting cases that occurred in the United States between 1982 and 2019 and involved shooters who survived and were brought to trial.
Analysis of various sources of medical evidence on the mass shooters showed that 28 had mental illness diagnoses. Eighteen had schizophrenia and 10 had other diagnoses including bipolar disorder, delusional disorder, personality disorders and substance-related disorders.
Of the 28 shooters with a mental illness diagnosis, none were medicated or received other treatment for their disorders prior to their crimes, according to the study published recently in the Journal of Clinical Psychopharmacology.
Glick and his colleagues also examined 20 mass shooters who died at the crime scene and found that eight had schizophrenia, seven had other mental health diagnoses, and five had unknown diagnoses. None were receiving appropriate medications.
The investigators pointed out that despite the high frequency of mass shooting events in the United States, there has been almost no medical research on the nature and incidence of mental illness among people who commit these crimes.
“The psychiatric disorders seen in perpetrators of mass shootings are serious brain illnesses — as much in need of proper diagnosis and treatment as heart disease or any other medical condition,” the authors noted in a Stanford news release.
“We need to reduce the stigma associated with these diseases to enable patients to receive appropriate and adequate psychiatric medication and other treatments,” they added, “by actually talking to patients and their significant others, we have the opportunity to save lives. 3,4-dihydro-2H-[1,3]oxazino[2,3-b]quinazolin-6-one manufacturer The Company has established a leadership position in the clinical development and manufacture of universal, off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform. 3,4-dihydro-2H-[1,3]oxazino[2,3-b]quinazolin-6-one supplier We found over half the products we tested contained elevated fluorine levels,” Bruton said.
The cosmetic categories that had the highest percentage of 213 high fluorine products were foundations (63%), eye products (58%), mascaras (47%), and lip products (55%), the study found.
Even more concerning was that cosmetics containing high levels of fluorine more often than not failed to disclose any PFAS chemicals on their labels, Bruton noted.
Further analysis of 29 cosmetics with high fluorine levels revealed that they contained between four and 13 specific PFAS chemicals, researchers found. However, only 1 of the 29 products listed PFAS as an ingredient on the product label.
“Even if a consumer is doing their due diligence and trying to avoid harmful chemicals by reading labels, our work is showing that these harmful chemicals are often not disclosed,” Bruton said.
Despite this, Bruton recommends that consumers who want to limit their exposure to PFAS read the labels anyway, to at least avoid products where the chemicals are accurately listed.
High levels of fluorine were frequently found in products advertised as “long-lasting” and “wear-resistant,” which could provide another clue for discerning consumers.
But in the end, there’s not much consumers can do to solve the problem.
“It’s important that the government step up to regulate ingredients in cosmetics with more stringency,” Bruton said. “It’s also time the cosmetics industry steps up and begins efforts to move away from this class of chemicals. 3,4-dihydro-2H-[1,3]oxazino[2,3-b]quinazolin-6-one vendor We found over half the products we tested contained elevated fluorine levels,” Bruton said.
The cosmetic categories that had the highest percentage of 213 high fluorine products were foundations (63%), eye products (58%), mascaras (47%), and lip products (55%), the study found.
Even more concerning was that cosmetics containing high levels of fluorine more often than not failed to disclose any PFAS chemicals on their labels, Bruton noted.
Further analysis of 29 cosmetics with high fluorine levels revealed that they contained between four and 13 specific PFAS chemicals, researchers found. However, only 1 of the 29 products listed PFAS as an ingredient on the product label.
“Even if a consumer is doing their due diligence and trying to avoid harmful chemicals by reading labels, our work is showing that these harmful chemicals are often not disclosed,” Bruton said.
Despite this, Bruton recommends that consumers who want to limit their exposure to PFAS read the labels anyway, to at least avoid products where the chemicals are accurately listed.
High levels of fluorine were frequently found in products advertised as “long-lasting” and “wear-resistant,” which could provide another clue for discerning consumers.
But in the end, there’s not much consumers can do to solve the problem.
“It’s important that the government step up to regulate ingredients in cosmetics with more stringency,” Bruton said. “It’s also time the cosmetics industry steps up and begins efforts to move away from this class of chemicals. 3,4-dihydro-2H-[1,3]oxazino[2,3-b]quinazolin-6-one factory We found over half the products we tested contained elevated fluorine levels,” Bruton said.
The cosmetic categories that had the highest percentage of 213 high fluorine products were foundations (63%), eye products (58%), mascaras (47%), and lip products (55%), the study found.
Even more concerning was that cosmetics containing high levels of fluorine more often than not failed to disclose any PFAS chemicals on their labels, Bruton noted.
Further analysis of 29 cosmetics with high fluorine levels revealed that they contained between four and 13 specific PFAS chemicals, researchers found. However, only 1 of the 29 products listed PFAS as an ingredient on the product label.
“Even if a consumer is doing their due diligence and trying to avoid harmful chemicals by reading labels, our work is showing that these harmful chemicals are often not disclosed,” Bruton said.
Despite this, Bruton recommends that consumers who want to limit their exposure to PFAS read the labels anyway, to at least avoid products where the chemicals are accurately listed.
High levels of fluorine were frequently found in products advertised as “long-lasting” and “wear-resistant,” which could provide another clue for discerning consumers.
But in the end, there’s not much consumers can do to solve the problem.
“It’s important that the government step up to regulate ingredients in cosmetics with more stringency,” Bruton said. “It’s also time the cosmetics industry steps up and begins efforts to move away from this class of chemicals.